Trial intelligence / Profile preview

Norepinephrine weaning guided by dynamic arterial elastance in cardiac surgery

NCT02479529Phase 3Completed

Sponsor
CHU Amiens-Picardie
Start
Oct 2014
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of norepinephrine in vasoplegic syndrome (VPS), sponsored by CHU Amiens-Picardie. Started Oct 2014; status: completed.

02

Drugs

norepinephrine
03

Conditions

vasoplegic syndrome (VPS)

Beyond the preview

Go deeper on NCT02479529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02479529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call